Direct visualization of mouse brain oxygen distribution by electron paramagnetic resonance imaging: application to focal cerebral ischemia.
Electron paramagnetic resonance imaging (EPRI) is a new modality for visualizing O(2) distribution in tissues, such as the brain after stroke or after administration of drugs of abuse. We have recently shown that 3-acetoxymethoxycarbonyl-2,2,5,5-tetramethyl-1-pyrrolidinyloxyl [1] is a pro-imaging agent that can cross the blood-brain barrier. After hydrolysis by esterases, the anion of 3-carboxy-2,2,5,5-tetramethyl-1-tetramethyl-1-pyrrolidinyloxyl [2] is trapped in brain tissue. In this study, we investigated the feasibility of using this to map the changes of O(2) concentration in mouse brain after focal ischemia. The decrease in tissue O(2) concentration in the ischemic region of mouse brain was clearly visualized by EPRI. The hypoxic zone mapped by EPRI was spatially well correlated with the infarction area in the brain imaged by diffusion-weighted magnetic resonance imaging (MRI). Finally, we observed a decrease in the size of the hypoxic region when the mouse breathed higher levels of O(2). This finding suggests that EPRI with specifically designed nitroxides is a promising imaging modality for visualizing O(2) distribution in brain tissue, especially in an ischemic brain. We believe that this imaging method can be used for monitoring the effects of therapeutic intervention aimed at enhancing brain O(2) supply, which is crucial in minimizing brain injury after stroke.
Shen
Jiangang
J
Center of Biomedical Research Excellence, College of Pharmacy, University of New Mexico, Albuquerque, New Mexico 87131, USA.
Sood
Rohit
R
Weaver
John
J
Timmins
Graham S
GS
Schnell
Aaron
A
Miyake
Minoru
M
Kao
Joseph P Y
JP
Rosen
Gerald M
GM
Liu
Ke Jian
KJ
D000818:Animals; D001921:Brain / Q000378:metabolism; D002545:Brain Ischemia / Q000378:metabolism* / Q000473:pathology; D001931:Brain Mapping / Q000379:methods*; D003952:Diagnostic Imaging / Q000379:methods; D004578:Electron Spin Resonance Spectroscopy / Q000379:methods*; D000860:Hypoxia; D008279:Magnetic Resonance Imaging; D051379:Mice; D010100:Oxygen / Q000032:analysis*
D010100:Oxygen
Bioconjug Chem. 2008 Oct;19(10):2068-71
18783260
Stroke. 2003 Nov;34(11):2729-35
14576370
Stroke. 2005 Feb;36(2):388-97
15618445
Radiology. 2005 Dec;237(3):919-26
16304112
Org Biomol Chem. 2005 Feb 21;3(4):645-8
15703801
J Cereb Blood Flow Metab. 2006 Oct;26(10):1274-84
16421507
Undersea Hyperb Med. 1994 Sep;21(3):245-9
7950798
Magn Reson Med. 2006 May;55(5):1157-63
16596636
J Neurochem. 2009 Feb;108(3):811-20
19187098
Magn Reson Med. 2006 Oct;56(4):938-43
16964613
J Cereb Blood Flow Metab. 2004 Dec;24(12):1369-81
15625411
Magn Reson Med. 2003 Apr;49(4):682-91
12652539
NMR Biomed. 2004 Aug;17(5):335-51
15366033
Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):834-43
15183487
Magn Reson Med. 2006 Jun;55(6):1433-40
16680679
Stroke. 1989 Jan;20(1):84-91
2643202
Magn Reson Med. 2005 Nov;54(5):1317-20
16193470
Magn Reson Med. 2008 Mar;59(3):619-25
18224698
NMR Biomed. 2004 Aug;17(5):327-34
15366032
Breast Dis. 1998 Aug;10(3-4):209-20
15687576
Free Radic Biol Med. 2000 Mar 15;28(6):959-69
10802228
Magn Reson Med. 2004 Sep;52(3):650-7
15334586
Antioxid Redox Signal. 2004 Jun;6(3):597-603
15130286
J Pharmacol Exp Ther. 2006 Sep;318(3):1187-93
16757536
Magn Reson Imaging. 2003 Sep;21(7):765-72
14559341
J Cereb Blood Flow Metab. 2002 Jul;22(7):861-8
12142571
Biochemistry. 2003 Jan 14;42(1):23-9
12515536
Biophys J. 2003 Feb;84(2 Pt 1):1291-8
12547809
Lancet. 1997 Nov 29;350(9091):1595-6
9393340
Magn Reson Med. 2005 Jul;54(1):87-95
15968657
Curr Opin Neurol. 1999 Feb;12(1):65-71
10097887
FEBS Lett. 1997 Dec 8;419(1):99-102
9426228
Neurology. 2002 Mar 26;58(6):945-52
11914413
NMR Biomed. 2004 Aug;17(5):226-39
15366025
Magn Reson Med. 2005 May;53(5):1158-65
15844139
Adv Exp Med Biol. 2005;566:179-85
16594151
Org Biomol Chem. 2004 Jan 7;2(1):99-102
14737666
Brain Res. 1995 Jul 10;685(1-2):91-8
7583257